Contrive Datum Insights has published "Home Healthcare Market Size, Share & Industry Analysis, By Equipment (Skilled Home Healthcare Services, Therapeutic Equipment, Diagnostic & Monitoring Devices, Mobility Assist & Home Medical Furniture), Indication (Cardiovascular Disorders & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Cancer, Wound Care, Other Indications), End user (Geriatric Patients, Patients with Chronic Diseases, Post-Acute & Post-Surgical Patients, Maternal & Pediatric Patients), Distribution channel (Home Healthcare Agencies, Retail Pharmacies & DME Stores, Online Channels, Hospital-Affiliated Home Care Programs), Payment mode (Private Insurance, Public Insurance / Government Programs, Out-of-Pocket), and Regional Forecast, 2026-2034". The study sizes the global home healthcare market at USD 420 billion in 2025 and projects growth from USD 451.5 billion in 2026 to USD 743.05 billion by 2034, a compound annual growth rate of 6.43% across the forecast period.
Home healthcare covers medical equipment, diagnostic devices, and clinical services delivered to patients in their own residences rather than in a hospital or clinic setting. It spans therapeutic devices such as respiratory and infusion equipment, diagnostic and monitoring tools, mobility aids and home medical furniture, and skilled services including nursing, therapy and hospice care. Buyers include individual patients and family caregivers, home healthcare agencies and hospital-based home care programs, and the insurers and government payers that reimburse this care.
Aging population and chronic disease burden expanding demand for home-based care
Aging population and chronic disease burden expanding demand for home-based care is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.43% a year, the equipment lines exposed to it move fastest: Diagnostic & Monitoring Devices compounds at 7.92%, taking its share of revenue from 23.79% to 27% and its value from USD 99.9 billion to USD 200.62 billion.
A more favourable outcome is possible. If faster expansion of public and private reimbursement for home-based care, combined with quicker adoption of connected monitoring devices, pulls forward demand across all regions, 2034 revenue reaches USD 818.86 billion instead of the USD 743.05 billion the base case carries.
Against that, slower reimbursement policy expansion and continued shortages of trained home healthcare staff constrain growth, particularly in service-heavy categories such as skilled nursing and hospice care. On that reading 2034 revenue stops at USD 629.04 billion. The weight of the problem sits in Skilled Home Healthcare Services: 34.93% of 2025 revenue growing at 5.76%, well under the market's 6.43%.
Where the Competition Actually Sits
The equipment axis, not the regional one, is what divides the field. Skilled Home Healthcare Services is the volume position, 34.93% of 2025 revenue at USD 146.7 billion, holding 33% through 2034, and it is defended by scale. Diagnostic & Monitoring Devices is the growth position at 7.92%, and it is open. Strength in one does not carry into the other.
Additional Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Indication | Cardiovascular Disorders & Hypertension | 24% · USD 100.8 billion | Cancer 8.95% |
| End user | Geriatric Patients | 42% · USD 176.4 billion | — |
| Distribution channel | Home Healthcare Agencies | 45% · USD 189 billion | Online Channels 12.12% |
| Payment mode | Private Insurance | 46% · USD 193.2 billion | Public Insurance / Government Programs 7.16% |
- Based on regional analysis, North America led the global home healthcare market in 2025 with 38.18% of global revenue at USD 160.35 billion, reaching USD 252.64 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24.21% in 2025 to 30% in 2034, with revenue growing from USD 101.7 billion to USD 222.92 billion.
- Middle East and Africa stays the smallest contributor across the period: 4.95% of revenue in 2025 and 4.5% in 2034.
- Skilled Home Healthcare Services was the leading equipment line in 2025, taking 34.93% of revenue at USD 146.7 billion.
- No equipment line grows faster than Diagnostic & Monitoring Devices, at a projected 7.92%.
- The United States is the largest single country market at USD 131.49 billion in 2025, 31.31% of global revenue.
The study covers five axes, by equipment, and by indication, end user, distribution channel and payment mode, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 629.04 billion and USD 818.86 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.